CLINICAL_TRIALS
trial_result
· 2025-09-12
Clinical Trial Update: A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis [Phase 2]
Summary
A Phase 2 study evaluating namilumab for chronic pulmonary sarcoidosis was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kinevant Sciences GmbH | Conditions: Sarcoidosis, Pulmonary | Phase 2 | Status: TERMINATED | Results posted: 2025-09-12